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Complex biological systems and cellular networks may underlie most genotype to phenotype
relationships. Here, we review basic concepts in network biology, discussing different types of
interactome networks and the insights that can come from analyzing them. We elaborate on why
interactome networks are important to consider in biology, how they can bemapped and integrated
with each other, what global properties are starting to emerge from interactome network models,
and how these properties may relate to human disease.Introduction
Since the advent of molecular biology, considerable progress
has been made in the quest to understand the mechanisms
that underlie human disease, particularly for genetically inherited
disorders. Genotype-phenotype relationships, as summarized in
the Online Mendelian Inheritance in Man (OMIM) database (Am-
berger et al., 2009), include mutations in more than 3000 human
genes known to be associated with one or more of over 2000
human disorders. This is a truly astounding number of geno-
type-phenotype relationships considering that a mere three
decades have passed since the initial description of Restriction
Fragment Length Polymorphisms (RFLPs) as molecular markers
to map genetic loci of interest (Botstein et al., 1980), only
two decades since the announcement of the first positional
cloning experiments of disease-associated genes using RFLPs
(Amberger et al., 2009), and just one decade since the release
of the first reference sequences of the human genome (Lander
et al., 2001; Venter et al., 2001). For complex traits, the informa-
tion gathered by recent genome-wide association studies
suggests high-confidence genotype-phenotype associations
between close to 1000 genomic loci and one or more of over
one hundred diseases, including diabetes, obesity, Crohn’s
disease, and hypertension (Altshuler et al., 2008). The discovery
of genomic variations involved in cancer, inherited in the germ-
line or acquired somatically, is equally striking, with hundreds
of human genes found linked to cancer (Stratton et al., 2009).
In light of new powerful technological developments such as
next-generation sequencing, it is easily imaginable that a catalog
of nearly all human genomic variations, whether deleterious,
advantageous, or neutral, will be available within our lifetime.
Despite the natural excitement emerging from such a huge
body of information, daunting challenges remain. Practically,
the genomic revolution has, thus far, seldom translated directly
into the development of new therapeutic strategies, and the
mechanisms underlying genotype-phenotype relationships
remain only partially explained. Assuming that, with time, most
human genotypic variations will be described together with986 Cell 144, March 18, 2011 ª2011 Elsevier Inc.phenotypic associations, there would still be major problems
to fully understand andmodel human genetic variations and their
impact on diseases.
To understand why, consider the ‘‘one-gene/one-enzyme/
one-function’’ concept originally framed by Beadle and Tatum
(Beadle and Tatum, 1941), which holds that simple, linear
connections are expected between the genotype of an organism
and its phenotype. But the reality is that most genotype-pheno-
type relationships arise from a much higher underlying com-
plexity. Combinations of identical genotypes and nearly identical
environments do not always give rise to identical phenotypes.
The very coining of the words ‘‘genotype’’ and ‘‘phenotype’’ by
Johannsen more than a century ago derived from observations
that inbred isogenic lines of bean plants grown in well-controlled
environments give rise to pods of different size (Johannsen,
1909). Identical twins, although strikingly similar, nevertheless
often exhibit many differences (Raser and O’Shea, 2005). Like-
wise, genotypically indistinguishable bacterial or yeast cells
grown side by side can express different subsets of transcripts
and gene products at any given moment (Elowitz et al., 2002;
Blake et al., 2003; Taniguchi et al., 2010). Even straightforward
Mendelian traits are not immune to complex genotype-pheno-
type relationships. Incomplete penetrance, variable expressivity,
differences in age of onset, and modifier mutations are more
frequent than generally appreciated (Perlis et al., 2010).
We, along with others, argue that the way beyond these chal-
lenges is to decipher the properties of biological systems, and in
particular, those of molecular networks taking place within cells.
As is becoming increasingly clear, biological systems and
cellular networks are governed by specific laws and principles,
the understanding of which will be essential for a deeper com-
prehension of biology (Nurse, 2003; Vidal, 2009).
Accordingly, our goal is to review key aspects of how complex
systems operate inside cells. Particularly, we will review how by
interacting with each other, genes and their products form
complex networks within cells. Empirically determining and
modeling cellular networks for a few model organisms and for
Figure 1. Perturbations in Biological Systems and Cellular Networks
May Underlie Genotype-Phenotype Relationships
By interacting with each other, genes and their products form complex cellular
networks. The link between perturbations in network and systems properties
and phenotypes, such as Mendelian disorders, complex traits, and cancer,
might be as important as that between genotypes and phenotypes.human has provided a necessary scaffold toward understanding
the functional, logical and dynamical aspects of cellular systems.
Importantly, wewill discuss the possibility that phenotypes result
from perturbations of the properties of cellular systems and
networks. The link between network properties and phenotypes,
including susceptibility to human disease, appears to be at least
as important as that between genotypes and phenotypes
(Figure 1).
Cells as Interactome Networks
Systems biology can be said to have originated more than half
a century ago, when a few pioneers initially formulated a theoret-
ical framework according to which multiscale dynamic complex
systems formed by interacting macromolecules could underlie
cellular behavior (Vidal, 2009). These theoretical systems biology
ideas were elaborated upon at a time when there was little
knowledge of the exact nature of the molecular components of
biology, let alone any detailed information on functional and
biophysical interactions between them. While greatly inspira-
tional to a few specialists, systems concepts remained largely
ignored by most molecular biologists, at least until empirical
observations could be gathered to validate them. Meanwhile,
theoretical representations of cellular organization evolved
steadily, closely following the development of ever improving
molecular technologies. The organizational view of the cell
changed from being merely a ‘‘bag of enzymes’’ to a web of
highly interrelated and interconnected organelles (Robinson
et al., 2007). Cells can accordingly be envisioned as complex
webs of macromolecular interactions, the full complement of
which constitutes the ‘‘interactome’’ network. At the dawn of
the 21st century, with most components of cellular networks
having been identified, the basic ideas of systems and network
biology are ready to be experimentally tested and applied to
relevant biological problems.Mapping Interactome Networks
Network science deals with complexity by ‘‘simplifying’’ com-
plex systems, summarizing themmerely as components (nodes)
and interactions (edges) between them. In this simplified
approach, the functional richness of each node is lost. Despite
or even perhaps because of such simplifications, useful discov-
eries can be made. As regards cellular systems, the nodes are
metabolites and macromolecules such as proteins, RNA mole-
cules and gene sequences, while the edges are physical,
biochemical and functional interactions that can be identified
with a plethora of technologies. One challenge of network
biology is to provide maps of such interactions using systematic
and standardized approaches and assays that are as unbiased
as possible. The resulting ‘‘interactome’’ networks, the networks
of interactions between cellular components, can serve as scaf-
fold information to extract global or local graph theory proper-
ties. Once shown to be statistically different from randomized
networks, such properties can then be related back to a better
understanding of biological processes. Potentially powerful
details of each interaction in the network are left aside, including
functional, dynamic and logical features, as well as biochemical
and structural aspects such as protein post-translational modifi-
cations or allosteric changes. The power of the approach resides
precisely in such simplification of molecular detail, which allows
modeling at the scale of whole cells.
Early attempts at experimental proteome-scale interactome
network mapping in the mid-1990s (Finley and Brent, 1994; Bar-
tel et al., 1996; Fromont-Racine et al., 1997; Vidal, 1997) were
inspired by several conceptual advances in biology. The bio-
chemistry of metabolic pathways had already given rise to
cellular scale representations of metabolic networks. The dis-
covery of signaling pathways and cross-talk between them, as
well as large molecular complexes such as RNA polymerases,
all involving innumerable physical protein-protein interactions,
suggested the existence of highly connected webs of interac-
tions. Finally, the rapidly growing identification ofmany individual
interactions between transcription factors and specific DNA
regulatory sequences involved in the regulation of gene expres-
sion raised the question of how transcriptional regulation is
globally organized within cells.
Three distinct approaches have been used since to capture
interactome networks: (1) compilation or curation of already
existing data available in the literature, usually obtained from
one or just a few types of physical or biochemical interactions
(Roberts, 2006); (2) computational predictions based on avail-
able ‘‘orthogonal’’ information apart from physical or biochem-
ical interactions, such as sequence similarities, gene-order
conservation, copresence and coabsence of genes in com-
pletely sequenced genomes and protein structural information
(Marcotte and Date, 2001); and (3) systematic, unbiased high-
throughput experimental mapping strategies applied at the scale
of whole genomes or proteomes (Walhout and Vidal, 2001).
These approaches, though complementary, differ greatly in the
possible interpretations of the resultingmaps. Literature-curated
maps present the advantage of using already available informa-
tion, but are limited by the inherently variable quality of the
published data, the lack of systematization, and the absence
of reporting of negative data (Cusick et al., 2009; TurinskyCell 144, March 18, 2011 ª2011 Elsevier Inc. 987
Figure 2. Networks in Cellular Systems
To date, cellular networks are most available for the ‘‘super-model’’ organisms (Davis, 2004) yeast, worm, fly, and plant. High-throughput interactome mapping
relies upon genome-scale resources such as ORFeome resources. Several types of interactome networks discussed are depicted. In a protein interaction
network, nodes represent proteins and edges represent physical interactions. In a transcriptional regulatory network, nodes represent transcription factors
(circular nodes) or putative DNA regulatory elements (diamond nodes); and edges represent physical binding between the two. In a disease network, nodes
represent diseases, and edges represent genemutations of which are associated with the linked diseases. In a virus-host network, nodes represent viral proteins
(square nodes) or host proteins (round nodes), and edges represent physical interactions between the two. In a metabolic network, nodes represent enzymes,
and edges represent metabolites that are products or substrates of the enzymes. The network depictions seem dense, but they represent only small portions of
available interactome network maps, which themselves constitute only a few percent of the complete interactomes within cells.et al., 2010). Computational prediction maps are fast and effi-
cient to implement, and usually include satisfyingly large
numbers of nodes and edges, but are necessarily imperfect
because they use indirect information (Plewczynski andGinalski,
2009). While high-throughput maps attempt to describe unbi-
ased, systematic, and well-controlled data, they were initially
more difficult to establish, although recent technological
advances suggest that near completion can be reached within
a few years for highly reliable, comprehensive protein-protein
interaction and gene regulatory network maps for human (Ven-
katesan et al., 2009).
The mapping and analysis of interactome networks for
model organisms was instrumental in getting to this point.
Such efforts provided, and will continue to provide, both neces-
sary pioneering technologies and crucial conceptual insights. As
with other aspects of biology, advancements inmapping of inter-
actome networks would have been minimal without a focus on
model organisms (Davis, 2004). The field of interactome
mapping has been helped by developments in several model
organisms, primarily the yeast, Saccharomyces cerevisiae, the
fly, Drosophila melanogaster, and the worm, Caenorhabditis
elegans (Figure 2). For instance, genome-wide resources such
as collections of all, or nearly all, open reading frames
(ORFeomes) were first generated for these model organisms,
both because their genomes are the best annotated and
because there are fewer complications, such as the high number
of splice variants in human and other mammals. ORFeome
resources allow efficient transfer of large numbers of ORFs into
vectors suitable for diverse interactome mapping technologies
(Hartley et al., 2000;Walhout et al., 2000b). Moreover, gene abla-
tion technologies, knockouts (for yeast) and knockdowns by
RNAi (for worms and flies) and transposon insertions (for plants),988 Cell 144, March 18, 2011 ª2011 Elsevier Inc.were discovered in and are being applied genome-wide for these
model organisms (Mohr et al., 2010).
Metabolic Networks
Metabolic network maps attempt to comprehensively describe
all possible biochemical reactions for a particular cell or
organism (Schuster et al., 2000; Edwards et al., 2001). In many
representations of metabolic networks, nodes are biochemical
metabolites and edges are either the reactions that convert
one metabolite into another or the enzymes that catalyze these
reactions (Jeong et al., 2000; Schuster et al., 2000) (Figure 2).
Edges can be directed or undirected, depending on whether
a given reaction is reversible or not. In specific cases of meta-
bolic network modeling, the converse situation can be used,
with nodes representing enzymes and edges pointing to adja-
cent pairs of enzymes for which the product of one is the
substrate of the other (Lee et al., 2008).
Although large metabolic pathway charts have existed for
decades (Kanehisa et al., 2008), nearly complete metabolic
network maps required the completion of full genome
sequencing together with accurate gene annotation tools (Ober-
hardt et al., 2009). Network construction is manual with compu-
tational assistance, involving: (1) the meticulous curation of large
numbers of publications, each describing experimental results
regarding one or several metabolic reactions characterized
from purified or reconstituted enzymes, and (2) when necessary,
the compilation of predicted reactions from studies of ortholo-
gous enzymes experimentally characterized in other species.
Assembly of the union of all experimentally demonstrated
and predicted reactions gives rise to proteome-scale network
maps (Mo and Palsson, 2009). Such maps have been
compiled for numerous species, predominantly prokaryotes
and unicellular eukaryotes (Oberhardt et al., 2009), and full-scale
metabolic reconstructions are now underway for human as
well (Ma et al., 2007). Metabolic network maps are likely the
most comprehensive of all biological networks, although consid-
erable gaps will remain to be filled in by direct experimental
investigations.
Protein-Protein Interaction Networks
In protein-protein interaction network maps, nodes represent
proteins and edges represent a physical interaction between
two proteins. The edges are nondirected, as it cannot be said
which protein binds the other, that is, which partner functionally
influences the other (Figure 2). Of the many methodologies that
can map protein-protein interactions, two are currently in wide
use for large-scale mapping. Mapping of binary interactions is
primarily carried out by ever improving variations of the yeast
two-hybrid (Y2H) system (Fields and Song, 1989; Dreze et al.,
2010). Mapping of membership in protein complexes, providing
indirect associations between proteins, is carried out by affinity-
or immunopurification to isolate protein complexes, followed by
some form of mass spectrometry (AP/MS) to identify protein
constituents of these complexes (Rigaut et al., 1999; Charbon-
nier et al., 2008). While Y2H datasets containmostly direct binary
interactions, AP/MS cocomplex data sets are composed of
direct interactions mixed with a preponderance of indirect
associations. Accordingly, the graphs generated by these two
approaches exhibit different global properties (Seebacher and
Gavin, 2011), such as the relationships between gene essenti-
ality and the number of interacting proteins (Yu et al., 2008).
In the past decade, significant steps have been taken toward
the generation of comprehensive protein-protein interaction
network maps. Comprehensive efforts using Y2H technologies
to generate interactome maps began with the model organisms
S. cerevisiae, C. elegans, and D. melanogaster (Ito et al., 2000,
2001; Uetz et al., 2000; Walhout et al., 2000a; Giot et al., 2003;
Reboul et al., 2003; Li et al., 2004), and eventually included
human (Colland et al., 2004; Rual et al., 2005; Stelzl et al.,
2005; Venkatesan et al., 2009). Comprehensive mapping of co-
complex membership by high-throughput AP/MS was initially
undertaken in yeast (Gavin et al., 2002; Ho et al., 2002), rapidly
progressing to ever improving completeness and quality there-
after (Gavin et al., 2006; Krogan et al., 2006). For technical
reasons future comprehensive AP/MS efforts will stay focused
on unicellular organisms such as yeast (Collins et al., 2007)
and mycoplasma (Kuhner et al., 2009), whereas Y2H efforts
are more readily implemented for complex multicellular organ-
isms (Seebacher and Gavin, 2011).
In their early implementations, systematic and comprehensive
interaction network mapping efforts met with skepticism
regarding their accuracy (von Mering et al., 2002), analogous
to the original concerns over whether automated high-
throughput genome sequencing efforts might have considerably
lower accuracy than dedicated efforts carried out cumulatively
in many laboratories. Only after the emergence of rigorous
statistical tests to estimate sequencing accuracy could high-
throughput sequencing efforts reach their full potential (Ewing
et al., 1998). Analogously, an empirical framework recently prop-
agated for protein interaction mapping (Venkatesan et al., 2009)now allows the estimation of overall accuracy and sensitivity for
maps obtained using high-throughput mapping approaches.
Four critical parameters need to be estimated: (1) complete-
ness: the number of physical protein pairs actually tested in a
given search space; (2) assay sensitivity: which interactions
can and cannot be detected by a particular assay; (3) sampling
sensitivity: the fraction of all detectable interactions found by a
single implementation of any interaction assay; and (4) precision:
the proportion of true biophysical interactors. Careful consider-
ation of these parameters offers a quantitative idea of the
completeness and accuracy of a particular high-throughput
interactionmap (Yu et al., 2008; Simonis et al., 2009; Venkatesan
et al., 2009), and allows comparison of multiple maps as long as
standardized framework parameters are used. In contrast,
comparing the results of small-scale experiments available in
literature curated databases is not possible, as there is little
way to control for accuracy, reproducibility, and sensitivity.
The binary interactome empirical framework offers a way to esti-
mate the size of interactome networks, which in turn is essential
to define a roadmap to reach completion for the interactome
mapping efforts of any species of interest. While originally estab-
lished for protein-protein interaction mapping, similar empirical
frameworks can be applied more broadly to mapping of other
types of interactome networks (Costanzo et al., 2010).
Gene Regulatory Networks
In most gene regulatory network maps, nodes are either a tran-
scription factor or a putative DNA regulatory element, and
directed edges represent the physical binding of transcription
factors to such regulatory elements (Zhu et al., 2009). Edges
canbesaid tobe incoming (transcription factor binds a regulatory
DNA element) or outgoing (regulatory DNA element bound by
a transcription factor) (Figure 2). Currently, two general
approaches are amenable to large-scale mapping of gene regu-
latorynetworks. In yeastone-hybrid (Y1H) approaches, aputative
cis-regulatory DNA sequence, commonly a suspected promoter
region, is used as bait to capture transcription factors that bind to
that sequence (Deplancke et al., 2004). In chromatin immunopre-
cipitation (ChIP) approaches, antibodies raisedagainst transcrip-
tion factors of interest, or against a peptide tag used in fusionwith
potential transcription factors, are used to immunoprecipitate
potentially interacting cross-linked DNA fragments (Lee et al.,
2002). As Y1H proceeds from genes and captures associated
proteins it is said to be ‘‘gene-centric,’’ whereas ChIP strategies
are ‘‘protein-centric’’ in that they proceed from transcription
factors and attempt to capture associated gene regions (Walh-
out, 2006). The two approaches are complementary. The Y1H
system can discover novel transcription factors but relies on
having known, or at least suspected, regulatory regions; ChIP
methods can discover novel regulatory motifs but rely on the
availability of reagents specific to transcription factors of interest,
which themselves depend on accurate predictions of transcrip-
tion factors (Reece-Hoyes et al., 2005; Vaquerizas et al., 2009).
Large-scale Y1H networks have been produced forC. elegans
(Vermeirssen et al., 2007; Grove et al., 2009). Large-scale ChIP-
based networks have been produced for yeast (Lee et al., 2002)
and have been carried out for mammalian tissue culture cells as
well (Cawley et al., 2004).Cell 144, March 18, 2011 ª2011 Elsevier Inc. 989
Figure 3. Integrated Networks
Coexpression and phenotypic profiling can be
thought of as matrices comprising all genes of an
organism against all conditions that this organism
has been exposed to within a given expression
compendium and all phenotypes tested, respec-
tively. For any correlation measurement, Pearson
correlation coefficients (PCCs) being commonly
used, the threshold between what is considered
coexpressed and noncoexpressed needs to be set
using appropriate titration procedures. Pairs of
genes whose expression or phenotype profiles are
above thedetermined threshold are then linked.The
resulting integrated networks have powerful pre-
dictive value. Adapted from (Gunsalus et al., 2005).In addition to transcription factor activities, overall gene tran-
script levels are also regulated post-transcriptionally by micro
RNAs (miRNAs), short noncoding RNAs that bind to complemen-
tary cis-regulatory RNA sequences usually located in 30 untrans-
lated regions (UTRs) of target mRNAs (Lee et al., 2004; Ruvkun
et al., 2004). miRNAs are not expected to act as master regula-
tors, but rather act post-transcriptionally to fine-tune gene
expression by modulating the levels of target mRNAs. Complex
networks are formed by miRNAs interacting with their targets. In
such networks, nodes are either a miRNA or a target 30UTR, and
edges represent the complementary annealing of the miRNA to
the target RNA. Edges can be said to be incoming (miRNA binds
a 30UTRelement) or outgoing (30UTRelement bound by amiRNA)
(Martinez et al., 2008). The targets of miRNAs are generally
computationally predicted, as experimental methodologies to
map miRNA/30UTR interactions at high-throughput are just
coming online (Karginov et al., 2007; Guo et al., 2010; Hafner
et al., 2010). Since transcription factors regulate the expression
of miRNAs, it is however possible to combine Y1H methods with
computationally predictedmiRNA/30UTR interactions, a strategy
which was used to derive a large-scale miRNA network in
C. elegans (Martinez et al., 2008) and which could be extended
to other genomes.
Integrating Interactome Networks with other Cellular
Networks
The three interactome network types considered so far, meta-
bolic, protein-protein interaction, and gene regulatory networks,
are composed of physical or biochemical interactions between
macromolecules. The corresponding network maps provide
crucial ‘‘scaffold’’ information about cellular systems, on top of
which additional layers of functional links can be added to fine-
tune the representation of biological reality (Figure 3) (Vidal,
2001). Networks composed of functional links, although strik-
ingly different in terms of what the edges represent, can never-
theless complement what can be learned from interactome
network maps in powerful ways, and vice versa. Networks of
functional links represent a category of cellular networks that
can be derived from indirect, or ‘‘conceptual,’’ interactions
where links between genes and gene products are reported990 Cell 144, March 18, 2011 ª2011 Elsevier Inc.based upon functional relationships or
similarities, independently of physical
macromolecular interactions. We con-sider three types of functional networks that have been mapped
thus far at the scale of whole genomes and used together with
physical interactome networks to interrogate the complexities
of genotype-to-phenotype relationships.
Transcriptional Profiling Networks
Gene products that function together in common signaling
cascades or protein complexes are expected to show greater
similarities in their expression patterns than random sets of
gene products. But how does this expectation translate at the
level of whole proteomes and transcriptomes? How do tran-
scriptome states correlate globally with interactome networks?
Since the original description of microarray and DNA chip tech-
niques and more recently de novo RNA sequencing using next-
generation sequencing technologies, vast compendiums of
gene expression datasets have been generated for many
different species across a multitude of diverse genetic and envi-
ronmental conditions. This type of information can be thought of
as matrices comprising all genes of an organism against all
conditions that this organism has been exposed to within a given
expression compendium (Vidal, 2001). In the resulting coexpres-
sion networks, nodes represent genes, and edges link pairs of
genes that show correlated coexpression above a set threshold
(Kim et al., 2001; Stuart et al., 2003). For any correlation
measurement, Pearson correlation coefficients (PCCs) being
commonly used, the threshold between what is considered
coexpressed and not coexpressed needs to be set using
appropriate titration procedures (Stuart et al., 2003; Gunsalus
et al., 2005).
Integration attempts in yeast, combining physical protein-
protein interaction maps with coexpression profiles, revealed
that interacting proteins are more likely to be encoded by genes
with similar expression profiles than noninteracting proteins (Ge
et al., 2001; Grigoriev, 2001; Jansen et al., 2002; Kemmeren
et al., 2002). These observations were subsequently confirmed
in many other organisms (Ge et al., 2003). Beyond the funda-
mental aspect of finding significant overlaps between interaction
edges in interactome networks and coexpression edges in tran-
scription profiling networks, these observations have been used
to estimate the overall biological significance of interactome
datasets. While correlations can be statistically significant over
huge datasets, still many valid biologically relevant protein-
protein interactions correspond to pairs of genes whose expres-
sion is uncorrelated or even anticorrelated. Coexpression
similarity links need not be perfectly overlapping with physical
interactions of the corresponding gene products and vice versa.
In another example of what coexpression networks can be
used for, preliminary steps have been taken to delineate gene
regulatory networks from coexpression profiles (Segal et al.,
2003; Amit et al., 2009). Such network constructions provide
verifiable hypotheses about how regulatory pathways operate.
Phenotypic Profiling Networks
Perturbations of genes that encode functionally related products
often confer similar phenotypes. Systematic use of gene knock-
out strategies developed for yeast (Giaever et al., 2002) and
knock-down approaches using RNA interference (RNAi) for
C. elegans, Drosophila, and, recently, human (Mohr et al.,
2010), are amenable to the perturbation of (nearly) all genes
and subsequent testing of a wide variety of standardized pheno-
types. As with transcriptional profiling networks, this type of
information can be thought of as matrices comprising all genes
of an organism and all phenotypes tested within a given pheno-
typic profiling compendium. In the resulting phenotypic similarity
or ‘‘phenome’’ network, nodes represent genes, and edges link
pairs of genes that show correlated phenotypic profiles above
a set threshold. Here again, titration is needed to decide on the
threshold between what is considered phenotypically similar
and what is not (Gunsalus et al., 2005).
The earliest evidence that phenotypic profiling or ‘‘phenome’’
networks might help in interpreting protein-protein interactome
networks was obtained in studies of theC. elegansDNA damage
response and hermaphrodite germline (Boulton et al., 2002;
Piano et al., 2002; Walhout et al., 2002). The physical basis of
phenome networks is not yet completely defined, though there
are strong overlaps between correlated phenotypic profiles
and physical protein-protein interactions (Walhout et al., 2002;
Gunsalus et al., 2005). Overlapping three network types, binary
interactions, coexpression, and phenotype profiling, produces
integrated networks with high predictive power, as demon-
strated for C. elegans early embryogenesis (Walhout et al.,
2002; Gunsalus et al., 2005). Integration of transcriptional regu-
latory networks with these other network types has also been
undertaken in worm (Grove et al., 2009).
Comprehensive genome-wide phenome networks are now a
reality for the yeast S. cerevisiae (Giaever et al., 2002), and are
expected to be further developed for C. elegans (So¨nnichsen
et al., 2005) and Drosophila (Mohr et al., 2010). Now that RNAi
reagents are available for nearly all genes of mouse and human
(Root et al., 2006), phenome maps for cell lines of these organ-
isms should soon follow.
Genetic Interaction Networks
Pairs of functionally related genes tend to exhibit genetic interac-
tions, defined by comparing the phenotype conferred by muta-
tions in pairs of genes (double mutants) to the phenotype
conferred by either one of these mutations alone (single
mutants). Genetic interactions are classified as negative, i.e.
aggravating, synthetic sick or lethal, when the phenotype of
double mutants is significantly worse than expected from that
of single mutants, and positive, i.e. alleviating or suppressive,when the phenotype of double mutants is significantly better
than that expected from the single mutants (Mani et al., 2008).
Though finding genetic interactions has been crucial to geneti-
cists for decades (Sturtevant, 1956; Novick et al., 1989), only in
the last ten years has functional genomics advanced sufficiently
to allow systematic high-throughput mapping of genetic interac-
tions to give rise to large-scale networks (Boone et al., 2007).
Two general strategies have been followed for the systematic
mapping of genetic interactions in yeast. Synthetic genetic
arrays (SGA) and derivative methodologies use high-density
arrays of double mutants by mating pairs from an available set
of single mutants (Tong et al., 2001; Boone et al., 2007). Alterna-
tive strategies take advantage of sequence barcodes embedded
in a set of yeast deletion mutants (Giaever et al., 2002; Beltrao
et al., 2010) to measure the relative growth rate in a population
of double mutants by hybridization to anti-barcode microarrays
(Pan et al., 2004; Boone et al., 2007). These two approaches
seem to capture similar aspects of genetic interactions, as the
overlap between the two types of datasets is significant (Cos-
tanzo et al., 2010).
Patterns of genetic interactions can be used to define a kind of
network that is similar to phenotypic profiling or phenome
networks. As with transcriptional and phenotypic profiling net-
works, this type of information can be thought of as matrices
comprising all genes of an organism and the genes with which
they exhibit a genetic interaction. In such ‘‘genetic interaction
profiling’’ networks, edges functionally link two genes based
on high similarities of genetic interaction profiles. Here again,
predictive models of biological processes can be obtained
when such networks are combined with other types of interac-
tome networks.
Integration of genetic interaction networks with other types of
interactome network maps provides potentially powerful
models. While genetic interactions do not necessarily corre-
spond to physical interactions between the corresponding
gene products (Mani et al., 2008), interesting patterns emerge
between the different datasets. Because they tend to reveal
pairs of genes involved in parallel pathways or in different molec-
ular machines, negative genetic interactions tend not to correlate
with either protein associations in protein complexes or with
binary protein-protein interactions (Beltrao et al., 2010; Costanzo
et al., 2010). In contrast, positive genetic interactions tend to
point to pairs of gene products physically associated with each
other. This trend is usually explained by loss of either one or
two gene products working together in a molecular complex
resulting in similar effects (Beltrao et al., 2010).
Graph Properties of Networks
A critical realization over the past decade is that the structure
and evolution of networks appearing in natural, technological,
and social systems over time follows a series of basic and repro-
ducible organizing principles. Theoretical advances in network
science (Albert and Barabasi, 2002), paralleling advances in
high-throughput efforts to map biological networks, have pro-
vided a conceptual framework with which to interpret large
interactome network maps. Full understanding of the internal
organization of a cell requires awareness of the constraints
and laws that biological networks follow. We summarize severalCell 144, March 18, 2011 ª2011 Elsevier Inc. 991
principles of network theory that have immediate applications to
biology.
Degree Distribution and Hubs
Any empirical investigation starts with the same question: could
the investigated phenomena have emerged by chance, or could
random effects account for them? The earliest network models
assumed that complex networks are wired randomly, such that
any two nodes are connected by a link with the same probability
p. This Erdos-Renyi model generates a network with a Poisson
degree distribution, which implies that most nodes have approx-
imately the same degree, that is, the same number of links, while
nodes that have significantly more or fewer links than any
average node are exceedingly rare or altogether absent. In
contrast, many real networks, from the world wide web to social
networks, are scale-free (Baraba´si and Albert, 1999), which
means that their degree distribution follows a power law rather
than the expected Poisson distribution. In a scale-free network
most nodes have only a few interactions, and these coexist
with a few highly connected nodes, the hubs, that hold the whole
network together. This scale-free property has been found in all
organisms for which protein-protein interaction and metabolic
network maps exist, from yeast to human (Baraba´si and Oltvai,
2004; Seebacher and Gavin, 2011). Regulatory networks,
however, show a mixed behavior. The outgoing degree distribu-
tion, corresponding to how many different genes a transcription
factor can regulate, is scale-free, meaning that some master
regulators can regulate hundreds of genes. In contrast, the
incoming degree distribution, corresponding to how many tran-
scription factors regulate a specific gene, best fits an exponential
model (Deplancke et al., 2006), indicating that genes that are
simultaneously regulated by large numbers of transcription
factors are exponentially rare.
Gene Duplication as the Origin of the Scale-Free
Property
The scale-free topology of biological networks likely originates
from gene duplication. While the principle applies from meta-
bolic to regulatory networks, it is best illustrated in protein-
protein interaction networks, where it was first proposed
(Pastor-Satorras et al., 2003; Va´zquez et al., 2003). When cells
divide and the genome replicates, occasionally an extra copy
of one or several genes or chromosomes gets produced. Imme-
diately following a duplication event, both the original protein and
the new extra copy have the same structure, so both interact
with the same set of partners. Consequently, each of the protein
partners that interacted with the ancestor gains a new interac-
tion. This process results in a ‘rich-get-richer’ phenomenon (Bar-
aba´si and Albert, 1999), where proteins with a large number of
interactions tend to gain links more often, as it is more likely
that they interact with a duplicated protein. This mechanism
has been shown to generate hubs (Pastor-Satorras et al.,
2003; Va´zquez et al., 2003), and so could be responsible for
the scale-free property of protein-protein interaction networks.
The Role of Hubs
Network biology attempts to identify global properties in interac-
tome network graphs, and subsequently relate such properties
to biological reality by integrating various functional datasets.
One of the best examples where this approach was successful is
in defining the role of hubs. In the model organisms S. cerevisiae992 Cell 144, March 18, 2011 ª2011 Elsevier Inc.and C. elegans, hub proteins were found to: (1) correspond to
essential genes (Jeong et al., 2001), (2) be older and have
evolved more slowly (Fraser et al., 2002), (3) have a tendency
to be more abundant (Ivanic et al., 2009), and (4) have a larger
diversity of phenotypic outcomes resulting from their deletion
compared to the deletion of less connected proteins (Yu et al.,
2008). While the evidence attributed to some of these findings
has been debated (Jordan et al., 2003; Yu et al., 2008; Ivanic
et al., 2009), the special role of hub proteins in model organisms
led to the expectation that, in humans, hubs should preferentially
encode disease-related genes. Indeed, upregulated genes in
lung squamous cell carcinoma tissues tend to have a high
degree in protein-protein interaction networks (Wachi et al.,
2005), and cancer-related proteins have, on average, twice as
many interaction partners as noncancer proteins in protein-
protein interaction networks (Jonsson and Bates, 2006). A
cautionary note is necessary: since disease-related proteins
tend to be more avidly studied their higher connectivity may be
partly rooted in investigative biases. Therefore, this type of
finding needs to be appropriately controlled using systematic
proteome-wide interactome network maps.
Understanding the role of hubs in human disease requires
distinguishing between essential genes and disease-related
genes (Goh et al., 2007). Some human genes are essential for
early development, such that mutations in them often lead to
spontaneous abortions. The protein products of mouse in utero
essential genes show a strong tendency to be associated with
hubs and to be expressed in multiple tissues (Goh et al., 2007).
Nonessential disease genes tend not to be encoded by hubs
and tend to be tissue specific. These differences can be best
appreciated from an evolutionary perspective. Mutations that
disrupt hubs may have difficulty propagating in the population,
as the host may not survive long enough to have offspring.
Only mutations that impair functionally and topologically periph-
eral genes can persist, becoming responsible for heritable
diseases, particularly those that manifest in adulthood.
Date and Party Hubs
Another success in uncovering the functional consequences of
the topology of interactome networks was provided by the
discovery of date and party hubs (Han et al., 2004). Upon inte-
grating protein-protein interaction network data with transcrip-
tional profiling networks for yeast, at least two classes of hubs
can be discriminated. Party hubs are highly coexpressed with
their interacting partners while date hubs appear to be more
dynamically regulated relative to their partners (Han et al.,
2004). In other words, date hubs interact with their partners at
different times and/or different conditions, whereas party hubs
seem to interact with their partners at all times or conditions
tested (Seebacher andGavin, 2011). Despite the preponderance
of evidence in its favor, the date and party hubs concept remains
a subject of debate, (Agarwal et al., 2010), attributable to the
necessity to appropriately calibrate coexpression and protein-
protein interaction hub thresholdswhen analyzing new transcrip-
tome and interactome datasets (Bertin et al., 2007).
Fundamentally, date hubs preferentially connect functional
modules to each other, whereas party hubs preferentially act
inside functional modules, hence they are occasionally called
inter-module and intra-module hubs, respectively (Han et al.,
2004; Taylor et al., 2009). Date hubs are less evolutionarily con-
strained than party hubs (Fraser, 2005; Ekman et al., 2006; Bertin
et al., 2007). Party hubs contain fewer and shorter regions of
intrinsic disorder than do date hubs (Ekman et al., 2006; Singh
et al., 2006; Kahali et al., 2009) and contain fewer linear motifs
(short binding motifs and post-translational modification sites)
than do date hubs (Taylor et al., 2009). Initially explored in a yeast
interactome (Han et al., 2004; Ekman et al., 2006), the distinction
between date and party hubs can be recapitulated in human
interactomes as well (Taylor et al., 2009).
Motifs
There has been considerable attention paid in recent years to
network motifs, which are characteristic network patterns, or
subgraphs, in biological networks that appear more frequently
than expected given the degree distribution of the network
(Milo et al., 2002). Such subgraphs have been found to be asso-
ciated with desirable (or undesirable) biological function (or
dysfunction). Hence identification and classification of motifs
can offer information about the various network subgraphs
needed for biological processes. It is now commonly understood
that motifs constitute the basic building blocks of cellular
networks (Milo et al., 2002; Yeger-Lotem et al., 2004).
Originally identified in transcriptional regulatory networks of
several model organisms (Milo et al., 2002; Shen-Orr et al.,
2002), motifs have been subsequently identified in interactome
networks and in integrated composite networks (Yeger-Lotem
et al., 2004; Zhang et al., 2005). Different types of networks
exhibit different motif profiles, suggesting a means for network
classification (Milo et al., 2004; Zhang et al., 2005). The high
degree of evolutionary conservation of motif constituents within
interaction networks (Wuchty et al., 2003), combined with the
convergent evolution that is seen in the transcription regulatory
networks of diverse species toward the same motif types (Bara-
ba´si and Oltvai, 2004), makes a strong argument that motifs are
of direct biological relevance. Classification of several highly
significant motifs of two, three, and four nodes, with descriptors
like coherent feed forward loop or single-input module, has
shown that specific types of motifs carry out specific dynamic
functions within cells (Alon, 2007; Shoval and Alon, 2010).
Topological, Functional, and Disease Modules
Most biological networks have a rather uneven organization.
Many nodes are part of locally dense neighborhoods, or topolog-
ical modules, where nodes have a higher tendency to link to
nodes within the same local neighborhood than to nodes outside
of it (Ravasz et al., 2002). A region of the global network diagram
that corresponds to a potential topological module can be iden-
tified by network clustering algorithms which are blind to the
function of individual nodes. These topological modules are
often believed to carry specific cellular functions, hence leading
to the concept of a functionalmodule, an aggregation of nodes of
similar or related function in the same network neighborhood.
Interest is increasing in disease modules, which represent
groups of network components whose disruption results in
a particular disease phenotype in humans (Baraba´si et al., 2010).
There is a tacit assumption, based on evidence in the biolog-
ical literature, that cellular components forming topological
modules have closely related functions, thus corresponding to
functional modules. New potentially powerful methods to iden-tify topological and functional clusterings continue to be
described (Ahn et al., 2010). Such modules can serve as hypoth-
esis building tools to identify regions of the interactome likely
involved in particular cellular functions or disease (Baraba´si
et al., 2010).
Networks and Human Diseases
Having reviewed why biological networks are important to
consider, how they can be mapped and integrated with each
other, and what global properties are starting to emerge from
such models, we next return to our original question: to what
extent do biological systems and cellular networks underlie
genotype-phenotype relationships in human disease? We
attempt to provide answers by covering four recent advances
in network biology: (1) studies of global relationships between
human disorders, associated genes and interactome networks,
(2) predictions of new human disease-associated genes using in-
teractome models, (3) analyses of network perturbations by
pathogens, and (4) emergence of node removal versus edge-
specific or ‘‘edgetic’’ models to explain genotype-phenotype
relationships.
Global Disease Networks
One of the main predictions derived from the hypothesis that
human disorders should be viewed as perturbations of highly
interlinked cellular networks is that diseases should not be inde-
pendent from each other, but should instead be themselves
highly interconnected. Such potential cellular network-based
dependencies between human diseases has led to the genera-
tion of various global disease network maps, which link disease
phenotypes together if some molecular or phenotypic relation-
ships exist between them. Such a map was built using known
gene-disease associations collected in the OMIM database
(Goh et al., 2007), where nodes are diseases and two diseases
are linked by an edge if they share at least one common gene,
mutations in which are associated with these diseases. In the
obtained disease network more than 500 human genetic disor-
ders belong to a single interconnected main giant component,
consistent with the idea that human diseases are much more
connected to each other than anticipated. The flipside of this
representation of connectivity is a network of disease-associ-
ated genes linked together if mutations in these genes are known
to be responsible for at least one common disorder. Providing
support for our general hypothesis that perturbations in cellular
networks underlie genotype-phenotype relationships, such
disease-associated gene networks overlap significantly with
human protein-protein interactome network maps (Goh et al.,
2007).
Additional types of connectivity between large numbers of
human diseases can be found in ‘‘comorbidity’’ networks where
diseases are linked to each other when individuals who were
diagnosed for one particular disease are more likely to have
also been diagnosed for the other (Rzhetsky et al., 2007; Hidalgo
et al., 2009). Diabetes and obesity represent probably the best
known disease pair with such significant comorbidity. While co-
morbidity can have multiple origins, ranging from environmental
factors to treatment side effects, its potential molecular origin
has attracted considerable attention. A network biology interpre-
tation would suggest that the molecular defects responsible forCell 144, March 18, 2011 ª2011 Elsevier Inc. 993
one of a pair of diseases can ‘‘spread along’’ the edges in cellular
networks, affecting the activity of related gene products and
causing or affecting the outcome of the other disease (Park
et al., 2009).
Predicting Disease Related Genes by Using Interactome
Networks
If cellular networks underlie genotype-phenotype relationships,
then network properties should be predictive of novel, yet to be
identified human disease-associated genes. In an early example,
it was shown that the products of a few dozen ataxia-associated
genes occupy particular locations in the human interactome
network, in that the number of edges separating them is on
average much lower than for random sets of gene products
(Lim et al., 2006). Physical protein-protein interactome network
maps can indeed generate lists of genes potentially enriched for
newcandidatediseasegenesormodifier genesof knowndisease
genes (Lim et al., 2006; Oti et al., 2006; Fraser and Plotkin, 2007).
Integration of various interactome and functional relationship
networks have also been applied to reveal genes potentially
involved in cancer (Pujana et al., 2007). Integrating a coexpres-
sion network, seeded with four well-known breast cancer
associated genes, together with genetic and physical interac-
tions, yielded a breast cancer network model out of which candi-
date cancer susceptibility andmodifier genes could be predicted
(Pujana et al., 2007). Integrative network modeling strategies are
applicable to other types of cancer and other types of disease
(Ergun et al., 2007; Wu et al., 2008; Lee et al., 2010).
Network Perturbations by Pathogens
Pathogens, particularly viruses, have evolved sophisticated
mechanisms to perturb the intracellular networks of their hosts
to their advantage. As obligate intracellular pathogens, viruses
must intimately rewirecellularpathways to their ownends tomain-
tain infectivity. Since many virus-host interactions happen at the
level of physical protein-protein interactions, systematic maps
capturing viral-host physical protein-protein interactions, or
‘‘virhostome’’ maps, have been obtained using Y2H for Epstein-
Barr virus (Calderwood et al., 2007), hepatitis C virus (de Chassey
et al., 2008), several herpesviruses (Uetz et al., 2006), influenza
virus (Shapira et al., 2009) and others (Mendez-Rios and Uetz,
2010), and by co-AP/MS methodologies for HIV (Ja¨ger et al.,
2010). An eminent goal is to find perturbations in network proper-
ties of the host network, properties that would not be made
evident by small-scale investigations focused on one or a handful
of viral proteins. For instance, it has been found several times
now that viral proteins preferentially target hubs in host
interactome networks (Calderwood et al., 2007; Shapira et al.,
2009). The many host targets identified in virhostome screens
are now getting biologically validated by RNAi knock-down and
transcriptional profiling, leading to detailed maps of the interac-
tions underlying viral-host relationships (Shapira et al., 2009).
Another impetus for mapping virhostome networks is that
virus protein interactions can act as surrogates for human
genetic variations, inducing disease states by influencing local
and global properties of cellular networks. The inspiration for
this concept emerged from classical observations such as the
binding of Adenovirus E1A, HPV E7, and SV40 Large T antigen
to the human retinoblastoma protein, which is the product of
a gene in which mutations lead to a predisposition to retinoblas-994 Cell 144, March 18, 2011 ª2011 Elsevier Inc.toma and other types of cancers (DeCaprio, 2009). This hypoth-
esis will soon be tested globally by systematic investigations of
how host networks, including physical interaction, gene regula-
tory and genetic interaction networks, are perturbed upon viral
infection. Pathogen-host interaction mapping projects are also
in their first iterations, with similar goals of identifying emergent
global properties and disease surrogates. As microbial patho-
gens can have thousands of gene products relative to much
smaller numbers for most viruses, such projects will require
considerably more effort and time.
Edgetics
Our underlying premise throughout has been that phenotypic
variations of an organism, particularly those that result in human
disease, arise from perturbations of cellular interactome
networks. These alterations range from the complete loss of
a gene product, through the loss of some but not all interactions,
to the specific perturbation of a singlemolecular interactionwhile
retaining all others. In interactome networks these alterations
range from node removal at one end and edge-specific,
‘‘edgetic’’ perturbations at the other (Zhong et al., 2009). The
consequences on network structure and function are expected
to be radically dissimilar for node removal versus edgetic pertur-
bation. Node removal not only disables the function of a node but
also disables all the interactions of that node with other nodes,
disrupting in some way the function of all of the neighboring no-
des. An edgetic disruption, removing one or a few interactions
but leaving the rest intact and functioning, has subtler effects
on the network, though not necessarily on the resulting pheno-
type (Madhani et al., 1997). The distinction between node
removal and edgetic perturbation models can provide new clues
on mechanisms underlying human disease, such as the different
classes of mutations that lead to dominant versus recessive
modes of inheritance (Zhong et al., 2009).
The idea that the disruption of specific protein interactions
can lead to human disease (Schuster-Bockler and Bateman,
2008) complements canonical gene loss/perturbation models
(Botstein and Risch, 2003), and is poised to explain confounding
genetic phenomena such as genetic heterogeneity.
Matching the edgetic hypothesis to inherited human diseases,
approximately half of 50,000 Mendelian alleles available in the
human gene mutation database can be modeled as potentially
edgetic if one considers deletions and truncating mutations as
node removal, and in-frame point mutations leading to single
amino-acid changes and small insertions and deletions as
edgetic perturbations (Zhong et al., 2009). This number is prob-
ably a good approximation, since thus far disease-associated
genes predicted to bear edgetic alleles using this model have
been experimentally confirmed (Zhong et al., 2009). For genes
associated with multiple disorders and for which predicted
protein interaction domains are available, it was shown that
putative edgetic alleles responsible for different disorders tend
to be located in different interaction domains, consistent with
different edgetic perturbations conferring strikingly different
phenotypes.
Conclusion
A comprehensive catalog of sequence variations among the 7
billion human genomes present on earth might soon become
available. This information will continue to revolutionize biology
in general and medicine in particular for many decades and
perhaps centuries to come. The prospects of predictive and
personalized medicine are enormous. However, it should be
kept in mind that genome variations merely constitute variations
in the parts list and often fail to provide a description of themech-
anistic consequences on cellular functions.
Here, we have summarized why considering perturbations of
biological networks within cells is crucial to help interpret how
genome variations relate to phenotypic differences. Given their
high levels of complexity, it is no surprise that interactome
networks have not yet been mapped completely. The data and
models accumulated in the last decade point to clear directions
for the next decade. We envision that with more interactome
datasets of increasingly high quality, the trends reviewed here
will be fine tuned. The global properties observed so far and
those yet to be uncovered should help ‘‘make sense’’ of the enor-
mous body of information encompassed in the human genome.
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